Health Economics Feasibility Study- Specialised Commissioning
NHS EnglandcontractContracts Finder ↗Ref CF-1945000D0O000000rwimUAASME suitableVCSE suitablecomplete
Estimated value
£24k
Awarded value
£24k
Awarded 15 Oct 2023
Suppliers
1
Lots
1
1 awarded
Published
17 Oct 2023
Deadline 30 Aug 2023
Other contracts from NHS England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Matrix - Desk Booking System | call off | £105k | 08 May 2026 |
| Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028 | call off | £17k | 08 May 2026 |
| ID&V Checking Service | contract | £150k | 08 May 2026 |
| Xerox Managed Print renewal 26/27 | call off | £127k | 08 May 2026 |
| Manage Engine ServiceDesk Plus Licences | call off | £29k | 08 May 2026 |
| Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026 | contract | £105k | 08 May 2026 |
| Clinicals Run Maintain Transform | call off | £38.0m | 10 Apr 2026 |
| Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmes | contract | — | 07 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 07 Apr 2026 |
| CPIT System Integration to NHSE RAVS | contract | £500k | 01 Apr 2026 |
Other contracts awarded to COSTELLO MEDICAL CONSULTING LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| C149851_DHSC: OHID: Anorectal malformations Evidence Map | contract | £17k | 24 Mar 2023 |
| DHSC: OHID: Metachromatic Leukodystrophy (MLD) Evidence Map | contract | £16k | 20 Mar 2023 |
| Consultancy Services for Population Health Programme | contract | £44k | 29 Nov 2022 |
| Evidence Map on Screening for Cytomegalovirus | contract | £50k | 18 Jun 2021 |
| PHE - Corporate - Evidence Map on Biotinidase Deficiency | contract | £6k | 09 Jun 2021 |
| PHE - Corporate - Asymptomatic Bacteriuria Screening in Pregnancy | contract | £81k | 26 May 2021 |
| PHE - Corporate - Evidence Map on Neuronal Ceroid Lipofuscinosis Type 2 | contract | £11k | 21 Apr 2021 |
| PHE - Corporate - Screening for Duchenne Muscular Dystrophy | contract | £15k | 31 Mar 2021 |
| PHE - Corporate - A Clinical and Cost Effectiveness Model on Formalising New-born Screening for β-thalassaemia Major | contract | £81k | 03 Nov 2020 |
| PHE - Corporate - Ultrasound Screening for Fetal Presentation at 36 Weeks | contract | £11k | 02 Sept 2020 |